INMED PHARMACEUTICALS INC. Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
INMED PHARMACEUTICALS INC. (INM) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of -$11.36 thousand for the 12-month period ending 2022-06-30, per its 10-K filed 2023-09-29.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets · last filed 2023-09-29
- INMED PHARMACEUTICALS INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2022-06-30 was $0.00.
- INMED PHARMACEUTICALS INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2022-03-31 was $0.00.
- INMED PHARMACEUTICALS INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2020-06-30 was $24.00.
- INMED PHARMACEUTICALS INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2022 was -$11.36K.
- INMED PHARMACEUTICALS INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2021 was -$555.00.
- INMED PHARMACEUTICALS INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2020 was -$2.31K.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 3 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 6 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 9 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month |
|---|---|---|---|---|
| 2022-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-29 | $0.00 derived: sum of 2 quarters · filed 2023-09-29 | -$11.36K 10-K · filed 2023-09-29 | |
| 2022-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-15 | -$11.36K 10-Q · filed 2023-05-15 | ||
| 2021-12-31 | -$11.36K 10-Q · filed 2023-02-17 | |||
| 2021-06-30 | -$555.00 10-K · filed 2022-09-23 | |||
| 2020-06-30 | $24.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-24 | -$2.31K 10-K · filed 2021-09-24 | ||
| 2020-03-31 | -$2.33K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |